Publications by authors named "Xiaqing Huang"
Article Synopsis
- * Ureaplasma parvum was identified as a rare pathogenic cause of his condition through advanced genetic testing, despite the absence of typical responses to treatment and normal liver function tests.
- * The findings suggest that Ureaplasma parvum should be considered as a potential cause of septic arthritis, particularly in patients with atypical presentations and symptoms of hyperammonemia.
Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials.
BMC Med Res Methodol
July 2020
Background: Phase II clinical trials primarily aim to find the optimal dose and investigate the relationship between dose and efficacy relative to standard of care (control). Therefore, before moving forward to a phase III confirmatory trial, the most effective dose is needed to be identified.
Methods: The primary endpoint of a phase II trial is typically a binary endpoint of success or failure.